Britain backs GSK’s gene therapy for ‘bubble boy’ syndrome – Reuters
Reuters |
Britain backs GSK's gene therapy for 'bubble boy' syndrome
Reuters Britain's National Institute for Health and Care Excellence (NICE) said in draft guidance published on Friday that Strimvelis gene therapy used against adenosine deaminase deficiency, or ADA-SCID, improves overall survival compared with standard stem … NHS to fund gene therapy for 'bubble babies' – The Telegraph NICE approves gene therapy for rare 'bubble baby syndrome' NICE nod for GSK's 'bubble baby syndrome' gene therapy |
